Jeet Mahal

Directeur des opérations chez JASPER THERAPEUTICS, INC.

Fortune : 529 691 $ au 30/04/2024

52 ans

64 relations

Consumer Services

Health Technology

Finance

Postes actifs de Jeet Mahal

Sociétés	Poste	Début	Fin
JASPER THERAPEUTICS, INC.	Directeur des opérations	21/03/2022	-
	Investor Relations Contact	01/12/2019	-
	Directeur Financier/CFO	01/12/2019	25/09/2023
	Secrétaire Général	01/12/2019	-

Historique de carrière de Jeet Mahal

Anciens postes connus de Jeet Mahal

Sociétés	Poste	Début	Fin
PORTOLA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/12/2009	01/12/2019
JOHNSON & JOHNSON	Corporate Officer/Principal	-	-
COR Therapeutics, Inc. COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction	Corporate Officer/Principal	-	-
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.	Corporate Officer/Principal	-	-

Formation de Jeet Mahal

University of California, Berkeley	Undergraduate Degree
Illinois Institute of Technology	Graduate Degree
North Carolina State University	Graduate Degree
The Fuqua School of Business	Masters Business Admin
Duke University	Masters Business Admin

Statistiques

Internationale

Etats-Unis

Opérationnelle

Corporate Officer/Principal	4
Graduate Degree	2
Masters Business Admin	2

Sectorielle

Consumer Services	6
Health Technology	5
Finance	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Sociétés cotées	2
JASPER THERAPEUTICS, INC.	Finance
JOHNSON & JOHNSON	Health Technology

Entreprise privées	3
Portola Pharmaceuticals LLC Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.	Health Technology
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.	Health Technology
COR Therapeutics, Inc. COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction	Health Technology

Voir les connexions sociétés